{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&creator.label=Biography+information+for+Yvonne+Fovargue", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&creator.label=Biography+information+for+Yvonne+Fovargue", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&_metadata=all&creator.label=Biography+information+for+Yvonne+Fovargue", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&creator.label=Biography+information+for+Yvonne+Fovargue", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&creator.label=Biography+information+for+Yvonne+Fovargue", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2018-10-11T11%3A55%3A08.93Z&tablingMemberConstituency=Makerfield&creator.label=Biography+information+for+Yvonne+Fovargue", "items" : [{"_about" : "http://data.parliament.uk/resources/1698924", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1698924/answer", "answerText" : {"_value" : "
Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.<\/p>
The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.<\/p>
The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE\u2019s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-04-15", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "20612"} , {"_value" : "20613"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-15T08:04:14.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-03-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS Greater Manchester: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, when she last met with Greater Manchester NHS Board to discuss the statutory commissioning of NICE approved medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4034", "label" : {"_value" : "Biography information for Yvonne Fovargue"} } , "tablingMemberConstituency" : {"_value" : "Makerfield"} , "tablingMemberPrinted" : [{"_value" : "Yvonne Fovargue"} ], "uin" : "20611"} , {"_about" : "http://data.parliament.uk/resources/1698925", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1698925/answer", "answerText" : {"_value" : "
Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.<\/p>
The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.<\/p>
The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE\u2019s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-04-15", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "20611"} , {"_value" : "20613"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-15T08:04:14.563Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-03-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS Greater Manchester: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions NHS England have had with Greater Manchester NHS on their statutory responsibilities to commission NICE approved medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4034", "label" : {"_value" : "Biography information for Yvonne Fovargue"} } , "tablingMemberConstituency" : {"_value" : "Makerfield"} , "tablingMemberPrinted" : [{"_value" : "Yvonne Fovargue"} ], "uin" : "20612"} , {"_about" : "http://data.parliament.uk/resources/1698926", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1698926/answer", "answerText" : {"_value" : "
Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.<\/p>
The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.<\/p>
The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE\u2019s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-04-15", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "20611"} , {"_value" : "20612"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-15T08:04:14.597Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-03-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Technology"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what guidance her Department issues NHS trusts on establishing commissioning structures for Health Technology Assessments; and whether trusts have discretion to adopt different processes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4034", "label" : {"_value" : "Biography information for Yvonne Fovargue"} } , "tablingMemberConstituency" : {"_value" : "Makerfield"} , "tablingMemberPrinted" : [{"_value" : "Yvonne Fovargue"} ], "uin" : "20613"} , {"_about" : "http://data.parliament.uk/resources/1604145", "AnsweringBody" : [{"_value" : "Department for Business and Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1604145/answer", "answerText" : {"_value" : "
The call for evidence on the review of the personal insolvency closed on 23 October 2022. The Government is currently analysing the significant number of responses and feedback received and will publish its response in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"} } , "answeringMemberConstituency" : {"_value" : "Thirsk and Malton"} , "answeringMemberPrinted" : {"_value" : "Kevin Hollinrake"} , "dateOfAnswer" : {"_value" : "2023-03-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-22T17:06:18.533Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "214"} , "answeringDeptShortName" : {"_value" : "Business and Trade"} , "answeringDeptSortName" : {"_value" : "Business and Trade"} , "date" : {"_value" : "2023-03-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Insolvency: Companies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business and Trade, when the Government plans to publish its response to the consultation entitled Call for evidence: reviewing the personal insolvency landscape.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4034", "label" : {"_value" : "Biography information for Yvonne Fovargue"} } , "tablingMemberConstituency" : {"_value" : "Makerfield"} , "tablingMemberPrinted" : [{"_value" : "Yvonne Fovargue"} ], "uin" : "165345"} , {"_about" : "http://data.parliament.uk/resources/1604147", "AnsweringBody" : [{"_value" : "Department for Business and Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1604147/answer", "answerText" : {"_value" : "
The number of people entering a formal personal insolvency solution since the commencement of the personal insolvency review at the beginning of July 2022 until 28 February 2023 was 74,124.<\/p>
<\/p>